Skip to main content
Caplight Logo









TheraFluor, Inc.

TheraFluor, Inc.

Private
Portland, OregonHealthcare & Life Scienceshttps://therafluor.com/

Last Round

Grant

Jan 1, 2025

Total Funding Raised

$1.72M

Company Overview

TheraFluor, Inc. is a biotechnology company that develops photosensitive dyes and instrument platforms for fluorescence-guided cancer surgery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Medical Imaging, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Hardware Sales

AI Layer

Non-AI

Keywords

fluorescence-guided surgeryFGSnear-infrared imagingNIR imagingtumor resectionsurgical oncologytheranostic nanomedicinesurgical guidanceimage-guided surgerymedical imaging hardwareveterinary oncologynanoparticle imagingbiotech R&DSBIR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TheraFluor, Inc. Comparables

Compare TheraFluor, Inc. with similar companies based on industry and business-model similarity.

TheraFluor, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Blaze Bioscience, Inc.
84%
Antelope Surgical Solutions, Inc.
83%
Vergent Bioscience
80%

TheraFluor, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 1, 2025
GrantJul 1, 2024

TheraFluor, Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2025

    Received grant funding from Oregon Business Development Department and Oregon Innovation Council.

  • Jul 1, 2024

    $275K grant from the National Science Foundation.

TheraFluor, Inc. Filings

Explore SEC and related filing metadata, where available.

TheraFluor, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about TheraFluor, Inc.'s valuation, stock price, and market status.

Is TheraFluor, Inc. a public or private company?

TheraFluor, Inc. is a private company.

What is the current stock price of TheraFluor, Inc.?

TheraFluor, Inc. is a private company with no public stock price. Caplight tracks TheraFluor, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is TheraFluor, Inc. worth (valuation)?

Valuation information for TheraFluor, Inc. is not publicly available.

Can I buy TheraFluor, Inc. stock?

TheraFluor, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was TheraFluor, Inc.'s last funding round?

TheraFluor, Inc.'s most recent funding round was Grant on January 1, 2025.

Who are the main investors in TheraFluor, Inc.?

Key investors in TheraFluor, Inc. include Oregon Innovation Council, U.S. Department of Health and Human Services, Oregon Business Development Department, National Science Foundation.

Will TheraFluor, Inc. IPO soon?

No public IPO plans have been announced for TheraFluor, Inc..

How can I track TheraFluor, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TheraFluor, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPortland, Oregon
Employee Range2
Year Founded2018
Last FundingJan 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?